Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Acorda Therapeutics, Inc. - Common Stock (NQ:ACOR)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acorda Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
92 Biggest Movers From Friday
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... 
Via Benzinga
Acorda First Quarter 2022 Update: Webcast/Conference Call Scheduled for May 11, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
78 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Salarius Pharmaceuticals (NASDAQ:SLRX) stock moved upwards by 31.4% to $0.49 during Thursday's regular session. The current volume of 2.4 million shares is 738... 
Via Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Gainers CEA Industries Inc. (NASDAQ: CEAD) shares surged 33.4% to $2.7350 after the company reported it signed a $2.1 million contract. Yield10 Bioscience, Inc. (NASDAQ: YTEN)... 
Via Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus AbbVie Settles With Alvotech On Humira Biosimilar Patent Dispute AbbVie, Inc... 
Via Benzinga
Earnings Scheduled For March 9, 2022
Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (... 
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
Via Benzinga
Acorda Fourth Quarter/Year End 2021 Update: Webcast/Conference Call Scheduled for March 9, 2022
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR)... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Avinger (NASDAQ:AVGR) stock moved... 
Via Benzinga
Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
From Acorda Therapeutics, Inc.
Via Business Wire
John Varian Joins Acorda Therapeutics Board of Directors
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RA... 
Via Benzinga
Acorda Inks Distribution Pact In Germany For Inhaled Levodopa Powder; Q3 Earnings Beat Expectations
Acorda Therapeutics Inc (NASDAQ: ACOR) entered into distribution and supply agreements with Esteve Pharmaceuticals GmbH to commercialize Inbrija 33 mg (... 
Via Benzinga
Topics Earnings
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. T2... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume for Molecular Templates's stock is 937.9K as... 
Via Benzinga
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
From Acorda Therapeutics, Inc.
Via Business Wire
Return on Capital Employed Insights for Acorda Therapeutics
After pulling data from Benzinga Pro it seems like during Q2, Acorda Therapeutics (NASDAQ:ACOR) posted sales of $31.79 million. Earnings were up 42.24%, but Acorda Therapeutics... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The company's market cap stands at $8.1 billion.... 
Via Benzinga
Acorda Therapeutics Reports Second Quarter 2021 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... 
Via Benzinga
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
40 Stocks Moving in Monday's Pre-Market Session
Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.